Kampo treatment for cerebrospinal fluid hypovolemia

Abstract

Cerebrospinal fluid hypovolemia (CSFH) is a disease in which cerebrospinal fluid is reduced due to sustained or intermittent leakage of cerebrospinal fluid (cerebro­spinal fluid) from the cerebrospinal fluid cavity, and exhibits various symptoms. Epidural blood patch therapy (EBP) for cerebrospinal fluid leakage is recognized as an insurance indication, but there are still many problems in diagnosis and treatment. In this study, we examined patients who used Kampo medicine among 19 patients with CSFH who underwent laboratory hospitaliza­tion in our department in April 2017 to June 2018. EBP was administered to 17 out of 19 people. Twelve of them received Kampo medicine. As for the Kampo medicine used, there were 9 goreisan, 6 kakkonto, 3 keishikajyutubuto, 2 hochuekkito were administered. Representative cases are presented and discussed.